IL-17 is an emerging target for inflammatory skin disorders, and immunohistochemical analysis has revealed the presence of IL-17 A in both psoriatic and vitiligo lesions, suggesting a pathogenic role of IL17 also in this disorder [83]. This evidence concerns the gene IL17A and vitiligo.